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Background: Vascular endothelial growth factor A (VEGFA) is a major regulator of both physiological and
pathological angiogenesis. Associations between polymorphisms in VEGFA and complex disease have been
inconsistent. The parent from whom the allele was inherited may account for these inconsistencies. This study
examined the parent of origin effect on the expression of murine Vegfa.
Methods: Two homozygous, inbred mouse strains A/J (AJ) and 129x1/SvJ (129) were crossed to produce reciprocal
AJ129 and 129AJ offspring, respectively. RNA was extracted from cardiac tissue of 6 week old male (n = 8) and
female (n = 8) parental, and male and female F1 offspring mice (AJ129 n = 8 and 129AJ n = 8). Vegfa and Hif1a
expression levels were measured by qPCR and compared between the F1 offspring from the reciprocal crosses.
Results: We found significant differences in the expression of Vegfa in F1 offspring (AJ129 and 129AJ mice) of the
reciprocal crosses between AJ and 129 mice. Offspring of male AJ mice had significantly higher expression of Vegfa
than offspring of male 129 mice (p = 0.006). This difference in expression was not the result of preferential allele
expression (allelic imbalance). Expression of Hif1a, a transcriptional regulator of Vegfa expression, was also higher in
F1 offspring of an AJ father (p = 0.004).
Conclusion: Differences in Vegfa and Hif1a gene expression are likely the result of an upstream angiogenic
regulator gene that is influenced by the parent of origin. These results highlight the importance of including
inheritance information, such as parent of origin, when undertaking allelic association studies.
Keywords: Parent of origin, Epigenetics, Vascular endothelial growth factorBackground
Angiogenesis is the growth of capillary sized vessels. It
plays a critical role in wound healing and embryological
development, and in the pathogenesis of diseases such as
cancer. Promoting angiogenesis can aid in the treatment
of ischemia and myocardial infarction, while inhibition of
angiogenesis has been effective in the treatment of cancer.
Vascular endothelial growth factor A (VEGFA) is one of
the most potent inducers of angiogenesis, and is a major
regulator of both physiological and pathological angiogen-
esis. It has been shown to stimulate blood vessel formation
in animal models of ischemic cardiovascular disease [1],
has been trialled as a potential therapeutic for myocardial
ischemia [2], and therapies that inhibit VEGF are used in
the treatment of cancer [3].* Correspondence: c.chiu@uws.edu.au
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reproduction in any medium, provided the orA number of studies have investigated associations be-
tween polymorphisms within, or nearby, the VEGFA
gene and complex disease, including coronary artery dis-
ease [4], atherosclerosis [5], myocardial infarction [6],
and hypertension [7]. However, these sequence variants
explain only a small fraction of the estimated heritability
of the diseases studied, and the ability to replicate these
findings can prove difficult. For example, inconsistent
results have been shown when studying the association
between the development of coronary artery lesions in
individuals with Kawasaki disease with VEGFA polymor-
phisms [8,9]. Population differences, study power, and
choice of polymorphism may explain inconsistent re-
sults. Additionally, the parent from whom the variant
was inherited may also contribute to the inability to rep-
licate results across studies.
Parent of origin effects influence gene expression in
offspring and result in the preferential expression of thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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variety of mechanisms including imprinting, sex, epigen-
etic effects, and environmental influences during devel-
opment [10]. In genetic studies, parent of origin effects
are largely ignored; however, recent studies have found
evidence of parent of origin effects in breast cancer [11],
colorectal cancer [12], and type 2 diabetes [11]. These
findings highlight the importance of investigating the ef-
fects of parent of origin on phenotype and disease
susceptibility.
Due to the inconsistency in results when studying the
association between VEGFA and disease, this study
aimed to determine whether parent of origin effects in-
fluence the expression of Vegfa. This study was carried
out in cardiac tissue from F1 hybrids resulting from re-
ciprocal crosses of two inbred mouse strains.Methods
All experiments were carried out at the School of Medi-
cine Animal Facility, University of Western Sydney and
approved by the University of Western Sydney Animal
Ethics Committee. Two homozygous, inbred mouse
strains A/J (AJ) and 129x1/SvJ (129) were used. Crosses
between AJ male and 129 female, and 129 male and AJ
female produced reciprocal AJ129 and 129AJ offspring,
respectively. Male (n = 8) and female (n = 8) mice from
each of the parental strains were euthanised at six weeks
of age by cervical dislocation. Male and female offspring
were collected from each of the crosses (AJ129 n = 8 per
sex and 129AJ n = 8 per sex). The hearts were excised,
rinsed with PBS and flash frozen in LN2.RNA extraction, quantification and cDNA synthesis
Hearts were mechanically disrupted in the deep frozen
state using the ‘Mikro Dismembrator’ automated frozen tis-
sue disruptor (Sartorius, Germany), as previously described
[13]. Total RNA was extracted from powderised tissueTable 1 Primers and PCR conditions




















Hif1aR TCAAACTGAGTTAACCusing TRIzol (Sigma Aldrich, USA) as per manufacturer’s
protocol, followed by DNase I treatment using the ‘DNA-
free’ kit (Applied Biosciences, USA) according to the man-
ufacturer’s protocol. RNA were quantified using the
NanoPhotometer (Implen, Germany) and cDNA was
synthesised from 500 ng of RNA using Bioscript™ Reverse
Transcriptase and random hexamers (Bioline Pty Ltd,
Australia) according to the manufacturer’s protocol. Gen-
omic DNA was extracted using the QIAamp DNA Mini
Kit (Qiagen, Germany) as per the manufacturer’s protocol.Quantitative PCR
Quantitative PCR (qPCR) was used to measure mRNA
expression of Vegfa and hypoxic inducible factor 1 alpha
(Hif1a). Mitochondrial ribosomal protein S28 (Mrps28S),
18S ribosomal RNA (Rn18S), and hypoxanthine guanine
phosphoribosyl transferase (Hprt1) were used as normalising
genes. Primer sequences are described in Table 1. Indi-
vidual reactions (10 μl) contained 5× MyTaq PCR buf-
fer (Bioline), 0.4 U of MyTaq (Bioline), 1x SYBR Green
I dye, forward and reverse primers (10 μM), and 4 μl of
cDNA (or 4 μl water for no template controls). A
pooled sample of cDNA was serially diluted 1 in 5 to
generate a standard curve for each primer set, and the
efficiency of the reaction was calculated. The PCR reac-
tions were carried out in a MxPro3005P Real Time
PCR System (Stratagene, Agilent Technologies, USA)
under the conditions listed in Table 1, followed by a
dissociation curve. All samples were run in triplicate.Direct sequencing
Sanger sequencing was used to confirm the presence
of a polymorphism in the 30UTR of Vegfa (NCBI Refer-
ence Sequence: NM_001025250.3). Total RNA from the
parental strains and F1 offspring was amplified and
the purified PCR products were sequenced (Australian
Genome Research Facility, AUST). Sequence data wasto 30 PCR conditions
AATGCA 95°C 100 (95°C 40″; 60°C 30″; 72°C 30″) × 40
AAGCT Dissociation curve
CAGT 95°C 100 (95°C 40″; 62°C 30″; 72°C 30″) × 40
TTCTC Dissociation curve
AGAGT 95°C 100 (95°C 40″; 62°C 30″; 72°C 30″) × 40
CCTT Dissociation curve
TGAGAC 95°C 100 (95°C 40″; 65°C 30″; 72°C 30″) × 40
GGTTTG Dissociation curve
TCACC 95°C 100 (95°C 40″; 62°C 30″; 72°C 30″) × 40
CCATGT Dissociation curve
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Codes Corp, MI).
Measurement of allelic expression using amplification
refractory mutation systems (ARMS) PCR
Heterozygous F1 samples were evaluated for Vegfa allelic
expression imbalance using quantitative ARMS PCR.
The amplification primers (forward: CTTTCATCCCAT
TGTCTACC(G/A); reverse: TGTTATTGGTGTCTTCA
CTGGA) used in the assay generated a 188 bp amplicon.
The allele specific primers were run in parallel reactions.
Reactions were run under the following conditions: 95°C
10 min; 95°C 30 sec, 62°C 30 sec, 72°C 30 sec for 30
cycles; followed by a dissociation curve. Individual reac-
tions (10 μl) contained 5× MyTaq PCR buffer (Bioline),
0.4 U of MyTaq (Bioline), 1x SYBR Green I dye, forward
and reverse primers (10 μM), and 4 μl of cDNA (or 4 μl
water for no template controls). All reactions were
performed in triplicate. The ability of the primers to dis-
tinguish between the two alleles with high specificity was
assessed using cDNA from parental strains. Under these
conditions neither primer exhibited cross-reactivity with
the opposite allele. A standard curve was generated for
each primer pair using a dilution series (200 ng to 0.20 ng,
1 in 4) of heterozygous genomic DNA. This served as a
reference for the 50:50 allelic ratio as we would expect a
perfect 50:50 ratio of the two alleles in genomic DNA
from a heterozygote with a diploid genome. We avoided
using cDNA as a control as this would bias our results to-
wards the allele expression ratio of the reference sample.
Data analysis
For qPCR, cycle threshold (Ct) values for each sample were
calculated using the MxPRo QPCR software (Stratagene,
Agilent Technologies, USA). Triplicate Ct values were aver-
aged and the quantity (Q) of each sample was calculated
using the delta-delta Ct method [14]. Q values from the nor-
maliser genes were input into geNorm [15] and the geomet-
ric means from these genes were used to generate aFigure 1 Relative expression of Vegfa. a. Parental: AJ male compared to
(offspring of AJ male) compared to 129AJ (offspring of 129 male).normalisation factor (NF). The Q values of the genes of
interest were normalised by dividing by the NF value. Re-
sults are expressed as mean ± SE fold changes in expression.
Statistical significance between groups was determined
using a general linear model. Statistical analysis was
performed with PASW Statistics version 20. A P value
of <0.01 was considered significant to account for
multiple testing.Results
Heterozygous F1 hybrids (AJ129 and 129AJ) resulting
from reciprocal crosses of two inbred homozygous
strains (AJ and 129) were used in this study. Direct se-
quencing of the full Vegfa mRNA transcript in homozy-
gous parental strains and heterozygous F1 offspring
confirmed a single nucleotide polymorphism (SNP) at
the 30UTR of the gene (AJ = GG, 129 = AA, AJ129 and
129AJ = GA).Vegfa expression
This study compared the expression of Vegfa in AJ and
129 parental mice, and in male F1 offspring from recip-
rocal crosses (AJ129 and 129AJ), to determine whether
parent of origin influences mRNA expression. Strain
specific differences in Vegfa expression were seen be-
tween AJ and 129 mice, with Vegfa expression 1.5 fold
higher in male AJ mice compared to male 129 mice
(Figure 1a). No strain specific differences in Vegfa ex-
pression were observed between female AJ and female
129 mice (Figure 1b). In the male F1 offspring from the
reciprocal crosses, Vegfa expression was 1.7 fold higher
in AJ129 mice compared with 129AJ mice (Figure 1c).
To ascertain whether this difference in Vegfa expression
tracked with Y chromosome transmission, the expression
of Vegfa was measured in female parentals and offspring.
There was no difference in Vegfa expression between
parental AJ males versus females (p = 0.15), and female
offspring of AJ males had 1.3 fold increased expression129 male. b. Parental: AJ female compared to 129 female. c. F1: AJ129
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rocal cross.
Measurement of allelic expression
To determine whether differences in Vegfa mRNA ex-
pression between the F1 offspring from the reciprocal
crosses were the result of unequal expression of the ma-
ternally or paternally inherited allele, the expression of
each allele was measured using quantitative ARMS PCR.
The rs16821436 SNP in the 30UTR of Vegfa (G/A)
was used to differentiate expression of alleles in the F1
heterozygous mice. In the F1 offspring, the expression of
each allele relative to the homozygous parental strain
was significantly lower, as expected. The expression
of the G allele in the heterozygous AJ129 and 129AJ
mice was significantly lower, 43% and 43%, than the
homozygous AJ mice (Figure 2ai). Similarly, the ex-
pression of the A allele in the heterozygous offspring
was significantly lower, 47% and 45%, than the homo-
zygous 129 parental mice (Figure 2aii). No difference
in the expression of the G allele relative to the A allele
was seen within the F1 offspring (Figure 2bi and ii).
Additionally, there was no difference in the expression
ratio of the G allele to the A allele between the AJ129
and 129AJ offspring.
Hif1a expression
To determine whether differences in Vegfa expression
were the result of trans-acting regulatory elements, theFigure 2 Vegfa allelic expression. ai. Relative expression of the G allele in
ratio of the G allele to the A allele in AJ129 mice. bii. Expression ratio of thexpression of Hif1a, a transcription factor and known
activator of Vegfa was measured. The expression of
Hif1a was measured in the AJ and 129 parental strains
and in the F1 offspring of reciprocal crosses. The expres-
sion of Hif1a was 1.4 fold higher in male AJ compared
to male 129 mice (Figure 3a). No difference in Hif1a ex-
pression was observed between the female parental
strains (Figure 3b). In the male F1 mice, the expression
of Hif1a was 1.4 fold higher in AJ129 compared to
129AJ mice (Figure 3c).
Discussion
This study examined the parent of origin effect on the
expression of Vegfa, an important regulator of angiogen-
esis. We found significant differences in the expression
of Vegfa in F1 offspring (AJ129 and 129AJ mice) of the
reciprocal crosses between AJ and 129 mice. Specifically,
offspring of male AJ mice had significantly higher ex-
pression of Vegfa than offspring of male 129 mice. This
difference in expression was not the result of preferential
allele expression (allelic imbalance), as no difference in
the expression of the paternally or maternally inherited
allele was observed in the F1 heterozygotes. Expression
of Hif1a, a transcriptional regulator of Vegfa expression,
was also found to be significantly higher in F1 offspring
of an AJ father. These results cannot be explained by
Y chromosome transmission, as female offspring of AJ
fathers had increased expression of Vegfa. In addition,
the AJ female parentals had no difference in expressionmales. aii. Relative expression of the A allele in males. bi. Expression
e G allele to the A allele in 129AJ mice.
Figure 3 Relative expression of Hif1a. a. Parental: AJ male compared to 129 male. b. Parental: AJ female compared to 129 female. c. F1: AJ129
(offspring of AJ male) compared to 129AJ (offspring of 129 male).
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The DNA sequences of F1 heterozygotes are identical
on autosomal chromosomes and differ only on their sex
chromosomes. As Vegfa and Hif1a are not located on
sex chromosomes, this suggests that the observed differ-
ences in Vegfa and Hif1a gene expression are not a re-
sult of DNA sequence variation and may be explained
by a parent of origin effect.
Angiogenesis is a strictly regulated process that results
from a balance between pro and inhibitory angiogenic
factors. VEGF is a potent pro-angiogenic factor and its
expression is tightly controlled at a number of levels.
Cis-acting SNPs have been shown to alter Vegfa pro-
moter activity [16-18], while SNPs in the 30UTR have
been reported to affect expression via the binding of mi-
cro RNAs which affect mRNA stability [19,20]. The AJ
and 129 parental strains differed at a single nucleotide in
the 30UTR of Vegf [21]. In this study, the paternally and
maternally inherited alleles within the F1 offspring were
expressed equally, indicating that cis-acting regulatory
elements within, or nearby, the Vegfa gene were unlikely
to account for the observed differences in Vegfa gene ex-
pression. However, the presence of cis- acting regulatory
elements in genes known to regulate Vegfa expression,
which are influenced by parent of origin, may explain
the difference in Vegfa expression.
A number of trans-acting factors are known to regu-
late the expression of Vegfa. Transcription factors that
bind to response elements within the Vegfa promoter in-
clude hypoxia-inducible factor (HIF1) [22], nuclear fac-
tor (NF)-κB [23], activator protein (AP1) [24], and
specificity protein (SP1) [25]. HIF1 is a transcription fac-
tor that functions to restore oxygen homeostasis during
hypoxia via the regulation of genes involved in angiogen-
esis (Vegfa), glycolysis and vasodilation [26]. In this
study, Hif1a expression was significantly higher in the
F1 offspring of AJ males which corresponded to in-
creased Vegfa expression within these same animals. Im-
balanced expression of alleles within the Hif1a genecould not be assessed as the F1 mice were homozygous
[21]. No studies have reported a role for epigenetic
mechanisms in the regulation of Hif1 expression how-
ever, epigenetic regulation of von Hippel-Lindau (VHL),
an ubiquitin ligase that targets HIF1a for proteosomal
destruction under normoxic conditions, has been
reported. Hypermethylation of the VHL promoter in
renal cell carcinoma has been correlated with increased
HIF1a expression [27], and deletion of miR-23b has been
reported to reduce HIF1a and VEGFA expression via its
targeting of VHL [28]. Further work is needed to address
whether epigenetic mechanisms are involved in the
regulation of genes known to regulate Vegfa and Hif1a
expression in this mouse model.
Transgenerational epigenetic inheritance is another
mechanism that may explain the differences in expression
patterns between the F1 offspring from the reciprocal
crosses. It refers to genetic or environmental exposures in
the parent, which affect patterns of gene expression in
the offspring, without the offspring having inherited the
allele or been exposed to the environmental agent [29].
Examples of transgenerational epigenetic inheritance in-
clude DNA methylation, histone modifications, changes in
chromatin structure and the action of small non-coding
RNA all of which can result in epialleles. That is, alleles
that are variably expressed in the absence of genetic het-
erogeneity [30]. The epigenetic state is established during
early embryogenesis and can be influenced by whether the
allele is inherited from the mother or the father, as is the
case with the agouti viable yellow allele (Avy) in mice [31].
Parent of origin effects may be observed for a number of
genes, if these genes belong to pathways that are ultim-
ately regulated by epialleles. This may be the case in the
present study, where a regulator of genes involved in
angiogenesis is influenced by the parent of origin, and
downstream this alters the expression of both Hif1a and
Vegfa. Further work is required to establish which genes
are controlled by epigenetic mechanisms within the path-
way controlling angiogenesis.
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Our study demonstrates that parent of origin influences
Vegfa expression in mouse cardiac tissue, and the gen-
etic factors which determine gene expression are more
complex than simple Mendelian inheritance. Addition-
ally, given the common use of A/J and 129x1/SvJ strains
to generate genetically engineered mice, studies using
mixed genetic background mice, or studies using mice
after backcrossing, need to consider parent of origin in
addition to genetic variation. Finally, the identification of
epigenetic regulation in genes involved in angiogenesis
has important implications in how future genome-wide
association studies need to incorporate technologies,
which detect epigenetic and parent of origin informa-
tion, to provide more informative associations.
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